Novel radiolabeled antibody developed for diagnosis and treatment of solid tumors

A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding only to cancer cells and not to the related antigen IL13Rα1, which is widely expressed in healthy tissues. Tested in multiple cancer types, the radiolabeled antibody was effective at delineating malignancies at a low injected mass dose and has the potential to be translated into radioimmunotherapy applications.

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps, study shows

A new study by scientists at Hokkaido University has found that lower temperatures significantly increase the risk of gastroenteritis among Rohingya refugees living in Bangladesh’s Kutupalong and Nayapara camps. Gastroenteritis is a viral or bacterial infection that causes inflammation of the stomach and intestines, resulting in diarrhea, vomiting, and stomach pain.